Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2026-02-24 @ 4:46 AM
Study NCT ID:
NCT01579318
Status:
TERMINATED
Last Update Posted:
2023-05-15
First Post:
2012-04-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma
Sponsor:
OncoSec Medical Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OMS-I120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None